ll plates, we recommend to seed 0.94.0 x 105 adherent cells in
2 ml of medium per well
the day prior to transfection, and 1.03.5
x 106 suspension cells in 1.6 ml of medium
on the day of transfection.
The actual number of cells depends on cell type and size. If you prefer
to use a different culture format for your determination, please contact
QIAGEN Technical Services for the recommended number of adherent or suspension
cells to seed.
The optimal confluency at the time of transfection complex addition is normally
4080%. The optimal confluency should be determined for every new cell line
to be transfected, and kept constant in future experiments. This is achieved
by counting cells prior to seeding and by keeping the time period between
seeding and transfection constant. For suspension cells, split the cells
the day prior to the transfection experiment. This will ensure that the
cell density is not too high and that the cells are in optimal physiological
condition on the day of transfection.
Amount of DNA
The optimal quantity of plasmid DNA used for transfection is determined
by the properties of the transfected plasmid which include: type of promoter,
origin of replication, and plasmid size. Toxic effects may arise if too
much plasmid with a high expression rate is used. Conversely, if insufficient
plasmid with a low expression rate is used, gene expression may be too low.
Therefore, optimization of plasmid DNA concentration should be performed
for every new plasmid and/or new cell line used. A pipetting scheme for
optimizing the amount of DNA for transfection in 6-well plates is provided
in Figure 2.
Amount of Enhancer (Effectene Reagent
'"/>
Source:
Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Related biology technology :1.
Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell
Line2.
Optimizing Transfection Conditions for Studying Signal Transduction Pathways3.
Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells4.
Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal
Fibroblasts5.
Versatile Transfection Reagent Offers Low Toxicity and Consistent
Performance6.
Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells7.
Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection
of Mammalian Cells8.
High-Efficiency Transfections Achieved with New Low-Toxicity Reagent9.
Efficient Transfection of Neurospora Crassa10.
Eppendorf Multiporator Transfection Protocols for Eukaryotic
Cells11.
Efficient Transfection of Neurospora Crassa